The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mefatinib as first-line treatment of patients with advanced non–small cell lung cancer harboring rare EGFR mutations.
 
Pingli Wang
No Relationships to Disclose
 
Liming Cao
No Relationships to Disclose
 
Panwen Tian
No Relationships to Disclose
 
Shengxiang Ren
No Relationships to Disclose
 
Liyun Miao
No Relationships to Disclose
 
Chengzhi Zhou
No Relationships to Disclose
 
Yun Fan
No Relationships to Disclose
 
Yuping Li
No Relationships to Disclose
 
Dongqing Lv
No Relationships to Disclose
 
Xin Zhao
No Relationships to Disclose
 
Mei Yang
Employment - HangZhou ZhongMei HuaDong Pharmaceutical Company
 
Chaonan Zhu
Employment - HangZhou ZhongMei HuaDong Pharmaceutical Company
 
June Xu
Employment - HangZhou ZhongMei HuaDong Pharmaceutical Company
 
Yong Song
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Kai Wang
No Relationships to Disclose